Prostatic Hyperplasia
Conditions
Interventions
Healthy control group:None
Sponsors
Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 90 Years
Inclusion criteria
Inclusion criteria: Benign Prostatic Hyperplasia (BPH) Group: 1. Patients aged 50 years or older. 2. Presence of clear symptoms of prostatic hyperplasia, meeting the diagnostic criteria for BPH. 3. Subjects fully understand the patient information, agree to adhere to the study procedures, and sign the informed consent form. Healthy Control Group: 1. No history of malignant tumors. 2. No history of prostate-related diseases. 3. No significant underlying diseases. 4. Subjects fully understand the patient information, agree to adhere to the study procedures, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. History of malignant tumors; 2. Patients with a history of significant underlying diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PI-RADs score of Enhanced MRI of the prostate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Max Urine flow rate (Qmax);Prostate-specific antigen;International prostate symptom score; | — |
Countries
China
Contacts
Public ContactXu Bin
Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed